Click to Call
Curcumin: Miracle or Myth?
Ancient remedy is seen as a promising ally against diverse diseases; How credible are the claims?

01/23/2017 By Craig Weatherby with Jason Boehm

Unlike synthetic drugs, natural products are difficult to patent.

And it takes hundreds of millions of research dollars to gain FDA approval for a health claim.

The difficulty of obtaining patents and FDA approval explains why few dietary supplements are backed by robust — and extremely costly — clinical evidence.

Every so often, promising lab results on a natural product will prompt a university to spend money on a preliminary clinical trial.

Curcumin is one of the few supplements to have received even preliminary clinical study, and the results of those — while inconclusive — are very promising.

Those results probably would have been much more promising, except that most of the published studies were conducted using older, very poorly absorbed curcumin supplements.

Let’s take a closer look at the history, challenges, and healing potential of curcumin, and how to identify effective supplements.

What is curcumin?
Curcumin comes from turmeric, a tropical plant (Curcuma longa) that’s closely related to ginger and lemongrass.

And it's ground turmeric root that gives curry powder its distinctive yellow-orange color.

Turmeric is a key medicine in Ayurveda — India’s ancient healing tradition — whose practitioners prescribe the root for a wide variety of ailments.

Its bold color comes from three polyphenol-type antioxidants called curcuminoids, which — like the polyphenols in other colorful plant foods — possess beneficial properties.

All three of turmeric’s colorful antioxidant pigments are collectively referred to as “curcumin”.

Foods made with whole turmeric are a wonderfully tasty way to get curcumin, but turmeric only contains about five percent curcumin.

To enjoy curcumin’s full benefits, you’ll need to take it in supplement form. And as we’ll explain, not all curcumin supplements are created equal.

Curcumin’s rise to prominence
Unlike many dietary supplements, curcumin is no Johnny-come-lately.

Harvard chemists discovered curcumin in turmeric in 1815, and its chemical structure was defined in 1910.

The first evidence of curcumin’s benefit for a human disease (cholecystitis) was published in 1937, and its ability to inhibit the growth of staphylococcus, salmonella, and tuberculosis was documented in 1949.

In the 1970s, scientists documented cholesterol-lowering, anti-diabetic, anti-inflammatory, and antioxidant properties of curcumin.

And in the 1980s, research revealed that curcumin exerts anticancer effects in isolated cells and in animals.

Since then, curcumin has been studied in hundreds of cell and animal experiments, and its effects in humans have been probed in more than 70 preliminary clinical studies.

Antioxidant/antiinflammatory star 
Curcumin’s rise to prominence really began in 1995, when scientists at the University of Texas MD Anderson Cancer Center discovered curcumin’s potent anti-inflammatory properties and related antioxidant effects.

Those scientists discovered that curcumin exerts strong anti-inflammatory and antioxidant effects via its so-called “nutrigenomic” effects on our working genes.

Curcumin can also enhance the production of internally produced antioxidant enzymes such as glutathione.

Importantly, those particular genetic effects suggested that curcumin might offer exceptionally broad health benefits.

Curcumin’s health promise
Curcumin has probably been subjected to more clinical studies than any supplements other than vitamins, minerals, and omega-3 fish oil.

However, as is the case with many supplements, few of these trials have been rigorous enough to permit statistically sound conclusions (i.e., randomized, double-blind, placebo-controlled, and of sufficient size and duration).

And, as we'll explain, most — though not all — of the human studies published to date have used "raw" cucumin, which is very poorly absorbed. (See “Absorption problems muddy the evidence”, below)

That said, preliminary clinical trials testing the effects of curcumin in people have generally produced positive results.

The clinical results suggest that curcumin may improve inflammatory conditions including cancer, cardiovascular disease, diabetes, dementia, arthritis, and various inflammatory bowel disorders.

Four years ago, scientists from the MD Anderson Cancer Center published the most extensive literature review to date.

They found substantial clinical evidence that curcumin benefited participants suffering from a variety of health conditions (Gupta SC et al. 2013):

As they wrote, “Some promising effects have been observed in patients with various pro-inflammatory diseases including cancer, cardiovascular disease, arthritis, uveitis, ulcerative proctitis, Crohn’s disease, ulcerative colitis, irritable bowel disease, peptic ulcer, gastric ulcer, gastric inflammation, psoriasis, diabetes, renal conditions, AIDs, cholecystitis, hepatic conditions, and chronic bacterial prostatitis.”

To that long list we’d add these observations, including findings from clinical studies published since their 2013 evidence review:

  • Alzheimer’s disease. Lab and animal studies show that curcumin possesses neuroprotective and cognitive-enhancing properties, which suggests that hypothetically, it should help prevent or ameliorate Alzheimer’s and other forms of dementia. The few clinical trials conducted to date have not detected significant benefits from supplemental curcumin. However, as the researchers behind the negative studies emphasized, the curcumin used was unenhanced and very poorly absorbed, and some trials involved people with advanced disease, so the jury remains out.
  • Cancer. As MD Anderson Cancer Center researchers wrote in 2013, “… curcumin has exhibited activities against numerous cancer types in human clinical trials,” and as researchers from Italy’s University of Messina wrote earlier this year, “Curcumin is a promising molecule for the prevention and treatment of cancer.” More clinical studies are underway to determine whether curcumin — alone or with chemotherapy — can benefit people with common cancers.
  • Diabetes. Oxidative stress (free radicals) and inflammation play major roles in Type 2 diabetes and its cardiovascular complications. Laboratory and preliminary clinical evidence shows curcumin provides antioxidant, anti-inflammatory, and glucose-lowering benefits that might help prevent or treat Type 2 diabetes.
  • Obesity. Low-grade chronic inflammation promotes weight gain, and vice versa, especially if you gain weight around the midsection. Curcumin can help regulate fat metabolism and mimic the anti-inflammatory benefits of caloric restriction. Experimental evidence suggests that curcumin may help people lose weight and reduce the severity of obesity-related diseases.
  • Osteoarthritis. Preliminary clinical evidence suggests that enhanced forms of curcumin may improve osteoarthritis symptoms.
  • Premenstrual Syndrome (PMS). Two recent clinical studies from Iranian universities found that curcumin alleviated PMS symptoms, and identified the specific ways in which it probably produced those benefits.
  • Rheumatoid arthritis (RA). Researchers in one trial compared curcumin with a nonsteroidal anti-inflammatory drug (NSAID) in 18 patients with RA. Two weeks of taking 1.2 grams of curcumin per day improved morning stiffness, walking time, and joint swelling as well as an NSAID. A more recent study among 45 RA patients found curcumin comparable to a commonly prescribed NSAID (diclofenac sodium) for reducing tenderness and joint swelling.

Absorption problems muddy the evidence
Curcumin in its "raw" state is very poorly absorbed.

As researchers put it a few years back, “The potential health benefits of curcumin are limited by its poor solubility, low absorption from the gut, rapid metabolism and rapid systemic elimination.”

Most of clinical trials published to date employed raw curcumin, so the true health potential of curcumin awaits full revelation.

Fortunately, the absorption problem has been overcome using several different approaches, but most methods of enhancing absorption make curcumin very costly.

The simplest — and most cost-effective way by far — to enhance absorption is to combine curcumin with turmeric’s own “volatile” compounds, which may also provide some health benefits.

When you compare the cost of various “enhanced” curcumin supplements, the only one that combines curcumin with turmeric’s volatile oils — called BCM-95 — comes out on top.

(We hope that all clinical trials from now on will use enhanced forms of curcumin, which would provide a much fairer test of this extraordinary plant extract.)

In addition, curcumin is absorbed much better when it's consumed along with fats, either from foods, or from supplements such as fish oil, which also delivers beneficial omega-3s.

That’s why, for optimal absorption, it’s wise to take curcumin supplements with a meal that provides significant amounts of fat.

Interestingly, lab research shows that combining curcumin with omega-3 fatty acids and antioxidants may promote cancer cell apoptosis (“suicide”) and protect the body’s defensive natural killer (NK) cells against degradation.

And one study found that feeding cancerous mice fish oil plus curcumin shrank their tumors significantly.

Curcumin dose and safety considerations
Human studies suggest that curcumin is generally safe, even at high doses.

Specifically, they’ve found curcumin safe at doses of up to 10 to 12 grams a day over periods of up to three months.

That said, curcumin can affect the efficacy or toxicity of pharmaceutical drugs that are either transported by P-glycoprotein (PCP) or are substrates of cytochrome-type enzymes, including some cancer chemotherapy drugs.

So if you’re taking prescription drugs, check with your doctor or integrative physician before taking curcumin.

Along with these precautions, we should note some myths about curcumin safety including false allegations that it promotes kidney stones and gallstones.

Although the oxalates in turmeric promote formation of kidney stones, these compounds are virtually absent from curcumin.

Curcumin actually prevents gallstone and kidney stone formation in rodents, in part by promoting contraction of the gallbladder. However, that contracting effect may worsen the symptoms of existing gallstones.

People with bile duct obstruction, gallstones, and GI disorders including stomach ulcers and hyperacidity disorders should not take curcumin without the guidance of a physician.

Likewise, a doctor should monitor anyone with ulcers or GI inflammation who uses curcumin.

Finally, although there are no specific contraindications for pregnancy — and some evidence that curcumin may promote a healthier pregnancy — it makes sense for a pregnant women to check with her physician.


Sources

  • Allegra A, Innao V, Russo S, Gerace D, Alonci A, Musolino C. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies. Cancer Invest. 2016 Dec 20:1-22. [Epub ahead of print]
  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007 Nov-Dec;4(6):807-18. Epub 2007 Nov 14. Review.
  • Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), A novel bioenhanced preparation of curcumin. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
  • Antony B, Merina B, Rao SB. Enhancing the absorption of curcuminoids. Spice Board of India. July 2005, 23-26.
  • Antony B, Merina B. Bioavailability of Curcumax (BCM – 095™). Little Flower Medical Research Center, Angamaly, India (Research Center of Mahatma Gandhi University). September 2006. Spice Board of India.
  • Baum L et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008 Feb;28(1):110-3. doi: 10.1097/jcp.0b013e318160862c.
  • Belkacemi A, Doggui S, Dao L, Ramassamy C. Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev Mol Med. 2011 Nov 4;13:e34. doi: 10.1017/S1462399411002055. Review.
  • Brondino N, Re S, Boldrini A, Cuccomarino A, Lanati N, Barale F, Politi P. Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies. ScientificWorldJournal. 2014 Jan 22;2014:174282. doi: 10.1155/2014/174282. Review.
  • Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012 Nov;26(11):1719-25. doi: 10.1002/ptr.4639.
  • Chen F, Wang H, Xiang X, Yuan J, Chu W, Xue X, Zhu H, Ge H, Zou M, Feng H, Lin J. Curcumin increased the differentiation rate of neurons in neural stem cells via wnt signaling in vitro study. J Surg Res. 2014 Dec;192(2):298-304. doi: 10.1016/j.jss.2014.06.026.
  • Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011 Apr 25;74(4):664-9. doi: 10.1021/np1007262. Epub 2011 Mar 17.
  • Fanaei H, Khayat S, Kasaeian A, Javadimehr M. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Neuropeptides. 2016 Apr;56:25-31. doi: 10.1016/j.npep.2015.11.003.
  • Garcea G, Jones DJ, Singh R, et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer. 2004; 90: 1011-1015.
  • Ghodasara J, Pawar A, Deshmukh C, Kuchekar B Inhibitory effect of rutin and curcumin on experimentally-induced calcium oxalate urolithiasis in rats. Pharmacognosy Res. 2010 Nov;2(6):388-92. doi: 10.4103/0974-8490.75462.
  • Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem Toxicol. 2015 Sep;83:111-24. doi: 10.1016/j.fct.2015.05.022. Review.
  • Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, Martins RN. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease. Br J Nutr. 2016 Feb 14;115(3):449-65. doi: 10.1017/S0007114515004687. Review.
  • Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013 Jan;15(1):195-218. doi: 10.1208/s12248-012-9432-8. Review.
  • Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012 Mar;39(3):283-299.
  • Hamaguchi T, Ono K, Yamada M. REVIEW: Curcumin and Alzheimer's disease. CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x. Review.
  • Jäger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparative absorption of curcumin formulations. Nutr J. 2014 Jan 24;13:11. doi: 10.1186/1475-2891-13-11.
  • Khayat S, Fanaei H, Kheirkhah M, Moghadam ZB, Kasaeian A, Javadimehr M. Curcumin attenuates severity of premenstrual syndrome symptoms: A randomized, double-blind, placebo-controlled trial. Complement Ther Med. 2015 Jun;23(3):318-24. doi: 10.1016/j.ctim.2015.04.001.
  • Li Y, Li M, Wu S, Tian Y. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process? Lipids Health Dis. 2015 Sep 3;14:100. doi: 10.1186/s12944-015-0106-2.
  • Lim W, Jeong M, Bazer FW, Song G. Curcumin Suppresses Proliferation and Migration and Induces Apoptosis on Human Placental Choriocarcinoma Cells via ERK1/2 and SAPK/JNK MAPK Signaling Pathways. Biol Reprod. 2016 Aug 31. pii: biolreprod.116.141630. [Epub ahead of print]
  • Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother. 2017 Jan;85:102-112. doi: 10.1016/j.biopha.2016.11.098. Review.
  • Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther. 1999 Feb;13(2):245-9.
  • Rasyid A, Rahman AR, Jaalam K, Lelo A. Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr. 2002;11(4):314-8.
  • Sareen R, Jain N, Pandit V. Curcumin: a boon to colonic diseases. Curr Drug Targets. 2013 Sep;14(10):1210-8. Review.
  • Shakeri A, Sahebkar A. Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation. J Neurosci Res. 2016 Feb;94(2):111-3. doi: 10.1002/jnr.23696. 
  • Shubha MC, Reddy RR, Srinivasan K. Antilithogenic influence of dietary capsaicin and curcumin during experimental induction of cholesterol gallstone in mice. Appl Physiol Nutr Metab. 2011 Apr;36(2):201-9. doi: 10.1139/h10-102.
  • Shubha MC, Reddy RR, Srinivasan K. Antilithogenic influence of dietary capsaicin and curcumin during experimental induction of cholesterol gallstone in mice. Appl Physiol Nutr Metab. 2011 Apr;36(2):201-9. doi: 10.1139/h10-102.
  • Zhongfa L, Chiu M, Wang J, Chen W, Yen W, Fan-Havard P, Yee LD, Chan KK. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol. 2012 Mar;69(3):679-89. doi: 10.1007/s00280-011-1749-y. Epub 2011 Oct 4.
  • Zhou J, Miao H, Li X, Hu Y, Sun H, Hou Y. Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt. Inflamm Res. 2016 Nov 5. [Epub ahead of print]